Tel-Revelol 40/25 Tablet ER
By Tel-Revelol
Rx
10 Tablet in a Strip

Composition
Metoprolol Succinate(25mg) + Telmisartan(40mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
June, 2026

liver
When taking Tel-Revelol 40/25 Tablet ER, it is important to be cautious if you have liver disease. It may be necessary to adjust the dosage of the medication in such cases. Therefore, it is advisable to consult your doctor before using Tel-Revelol 40/25 Tablet ER to ensure your safety and well-being.

kidney
Tel-Revelol 40/25 Tablet ER is considered safe for patients with kidney disease. It is not necessary to adjust the dosage for patients with kidney issues.

alcohol
It is not safe to drink alcohol while taking Tel-Revelol 40/25 Tablet ER.

driving
When using Tel-Revelol 40/25 Tablet ER, be cautious when driving as it may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if these side effects are experienced.

pregnancy
Tel-Revelol 40/25 Tablet ER is considered unsafe during pregnancy due to potential risks to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. It is advisable to consult a doctor before use.

breastfeeding
Tel-Revelol 40/25 Tablet ER can be considered safe while breastfeeding. Human data shows no major risks to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹178
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024